Analysis of 3 urine specimens finds no common pattern.
A WHO official said the hospital cluster involves 17 illnesses, 9 of them fatal, and specimens from 6 people who died tested negative for Ebola.
Saudi Arabia's Ministry of Health (MOH) today announced a new MERS-CoV case, involving a 55-year-old expat man from Wadi Aldwasir who is hospitalized in critical condition. It's not clear if his illness is part of a recent hospital cluster reported from Wadi Aldwasir; he is not a healthcare worker and his infection source is listed as primary, meaning he didn't likely contract the virus from another person.
About 4% of patients traveled, a potential target for curbing disease spread.
The CEPI model could play a role, the experts say.
Zika virus has been silently circulating in West Africa for more than two decades, according to a study of 387 blood samples collected from 1992 to 2016, researchers from Harvard University, Nigeria, and Senegal reported in the Journal of Infectious Diseases.
The virus was first identified in 1947 but wasn't linked with known epidemics until 2007 and hadn't been linked to neurologic disease before 2015.
The phase 2 trials will enroll more than 5,000 adults and kids in Guinea and Liberia.
A prime-boost regimen in clinical trials shows immune response 1 year after vaccination.
Neuraminidase inhibitors, the antiviral drugs given to fight and prevent influenza, pose no safety risks to fetuses or newborns, according to a new study published today in BMJ. This is the largest study on antiviral use and safety in pregnancy conducted to date.
A federal ethics committee that reviewed a research proposal to experimentally infect humans with Zika virus to help gauge the best approach to a vaccine has rejected the application, according to a report posted last week and first reported today by Stat.
